Apol1-associated Kidney Disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2026-04-24
Clinical Trial Update: Janus Kinase-STAT Inhibition to Reduce APOL1 Associated Kidney Disease [Phase 2]
Phase 2 trial investigating a JAK-STAT pathway inhibitor for APOL1-associated kidney disease has completed (sponsor: Duke University).